Clinical effect of brachytherapy with125I seed implantation in treatment of malignant hepatopancreatobiliary tumors
10.3969/j.issn.1001-5256.2016.12.014
- VernacularTitle:碘-125粒子植入近程放疗在肝胆胰恶性肿瘤中的应用
- Author:
Xu JIANG
1
;
Jijin YANG
;
Hui LI
Author Information
1. Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
- Publication Type:Research Article
- Keywords:
liver neoplasms;
bile duct neoplasms;
pancreatic neoplasms;
iodine radioisotopes;
radiotherapy
- From:
Journal of Clinical Hepatology
2016;32(12):2300-2304
- CountryChina
- Language:Chinese
-
Abstract:
Malignant hepatopancreatobiliary tumors are highly malignant and have poor prognosis. 125I seed implantation combined with other minimally invasive therapies for radical treatment of early liver cancer has achieved a good clinical effect in preventing early recurrence after liver cancer surgery. It is also used in the treatment of advanced liver cancer and portal vein tumor thrombosis. 125I seed has achieved a good local control rate in the treatment of tumors with a lack of blood supply, such as intrahepatic cholangiocellular carcinoma and metastatic liver cancer. 125I seed combined with biliary stenting can significantly relieve the symptoms of malignant biliary obstruction and extend the time to restenosis. Comprehensive interventional treatment based on 125I seed can significantly improve quality of life and extend survival time in patients with pancreatic cancer. Therefore, 125I seed implantation is safe and convenient in clinical practice and holds promise for clinical application.
